AMRN Financials: Amarin Corporation PLC AI Analysis



Financials

AMRN Financial

Amarin Corporation PLC

$14.27

1.56%

$0.21

As of today:May 20, 16:48:57 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$14.05

Open

$14.29

Day's Range

$14.1 - $14.35

52 week range

$9.98 - $20.9

Volume

35.4K

Avg.Volume

80.5K

Dividend yield

EPS (TTM)

-1.46

Market Cap

$299.2M

What is AMRN?

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The firm operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	216	45	49	49	72	42
Revenue Growth (YoY)	1%	7%	-21%	17%	7%	-25%
Cost of Revenue	103	27	26	27	22	16
Gross Profit	113	17	23	22	50	25
Selling, General & Admin	80	1	20	19	38	36
Research & Development	19	4	5	4	4	5
Operating Expenses	99	6	25	23	43	41
Other Non Operating Income (Expenses)	3	0	2	0	0	0
Pretax Income	-31	-8	0	-8	-13	-13
Income Tax Expense	2	1	0	0	0	2
Net Income	-33	-10	-1	-7	-14	-15
Net Income Growth	-63%	-33%	-98%	-72%	-1,500%	67%
Shares Outstanding (Diluted)	419.05	419.05	416.11	415.53	20.72	20.67
Shares Change (YoY)	1,927%	1,927%	1,923%	1,921%	1%	1%
EPS (Diluted)	-0.08	-0.02	0	-0.01	-0.68	-0.75
EPS Growth	-98%	-97%	-100%	-98%	-1,075%	57.99%
Free Cash Flow	25	6	15	-12	16	-12
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	52.31%	37.77%	46.93%	44.89%	69.44%	59.52%
Operating Margin	6.48%	24.44%	-4.08%	-2.04%	8.33%	-38.09%
Profit Margin	-15.27%	-22.22%	-2.04%	-14.28%	-19.44%	-35.71%
Free Cash Flow Margin	11.57%	13.33%	30.61%	-24.48%	22.22%	-28.57%
EBITDA	16	11	-2	-1	6	-16
EBITDA Margin	7.4%	24.44%	-4.08%	-2.04%	8.33%	-38.09%
D&A For EBITDA	2	0	0	0	0	0
EBIT	14	11	-2	-1	6	-16
EBIT Margin	6.48%	24.44%	-4.08%	-2.04%	8.33%	-38.09%
Effective Tax Rate	-6.45%	-12.5%	0%	0%	0%	-15.38%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

216

Revenue Growth (YoY)

-21%

17%

-25%

Cost of Revenue

103

Gross Profit

113

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

-31

-8

-13

Income Tax Expense

Net Income

-33

-10

-1

-7

-14

-15

Net Income Growth

-63%

-33%

-98%

-72%

-1,500%

67%

Shares Outstanding (Diluted)

419.05

416.11

415.53

20.72

20.67

Shares Change (YoY)

1,927%

1,923%

1,921%

EPS (Diluted)

-0.08

-0.02

-0.01

-0.68

-0.75

EPS Growth

-98%

-97%

-100%

-98%

-1,075%

57.99%

Free Cash Flow

-12

Free Cash Flow Per Share

Gross Margin

52.31%

37.77%

46.93%

44.89%

69.44%

59.52%

Operating Margin

6.48%

24.44%

-4.08%

-2.04%

8.33%

-38.09%

Profit Margin

-15.27%

-22.22%

-2.04%

-14.28%

-19.44%

-35.71%

Free Cash Flow Margin

11.57%

13.33%

30.61%

-24.48%

22.22%

-28.57%

EBITDA

-2

-1

-16

EBITDA Margin

7.4%

24.44%

-4.08%

-2.04%

8.33%

-38.09%

D&A For EBITDA

EBIT

-2

-1

-16

EBIT Margin

6.48%

24.44%

-4.08%

-2.04%

8.33%

-38.09%

Effective Tax Rate

-6.45%

-12.5%

-15.38%

Follow-Up Questions

What are Amarin Corporation PLC's key financial statements?



According to the latest financial statement (Form-10K), Amarin Corporation PLC has a total asset of $0, Net loss of $0

What are the key financial ratios for AMRN?



Amarin Corporation PLC's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Amarin Corporation PLC's revenue broken down by segment or geography?



Amarin Corporation PLC largest revenue segment is Vascepa, at a revenue of 228,614,000 in the most earnings release.For geography, United States is the primary market for Amarin Corporation PLC, at a revenue of 166,701,000.

Is Amarin Corporation PLC profitable?



no, according to the latest financial statements, Amarin Corporation PLC has a net loss of $0

Does Amarin Corporation PLC have any liabilities?



no, Amarin Corporation PLC has liability of 0

How many outstanding shares for Amarin Corporation PLC?



Amarin Corporation PLC has a total outstanding shares of 0

Amarin Corporation PLC (AMRN) Financial

AMRN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AMRN?

Amarin Corporation PLC (AMRN) Financial

AMRN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AMRN?

AMRN Income

Follow-Up Questions

What are Amarin Corporation PLC's key financial statements?

What are the key financial ratios for AMRN?

How is Amarin Corporation PLC's revenue broken down by segment or geography?

Is Amarin Corporation PLC profitable?

Does Amarin Corporation PLC have any liabilities?

How many outstanding shares for Amarin Corporation PLC?